Lisa Sprinzen, PhD
Postdoctoral Scholar
Neurological Surgery
School of Medicine

Publications (2)

Top publication keywords:
Topoisomerase I InhibitorsLymphomaHistonesMorpholinesDisease Models, AnimalBenzamidesAtaxia Telangiectasia Mutated ProteinsBiphenyl CompoundsGliomaCarcinogenesisAnimalsHistone Deacetylase InhibitorsPyridonesMice

• EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor.
  Cells 2024 Sprinzen L, Garcia F, Mela A, Lei L, Upadhyayula P, Mahajan A, Humala N, Manier L, Caprioli R, Quiñones-Hinojosa A, Casaccia P, Canoll P
• Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors.
  eLife 2016 Yamamoto K, Wang J, Sprinzen L, Xu J, Haddock CJ, Li C, Lee BJ, Loredan DG, Jiang W, Vindigni A, Wang D, Rabadan R, Zha S